Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 21;159(8):e55.
doi: 10.1016/j.medcle.2022.06.005. Epub 2022 Oct 8.

Reply

David Berlana  1 , Ignacio Cardona-Pascual  1 , J Bruno Montoro-Ronsano  1
Affiliations

Reply

David Berlana et al. Med Clin (Engl Ed). .
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Cardona-Pascual I., Berlana D., Martinez-Valle F., Campany-Herrero D., Montoro-Ronsano J.B. Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia [Article in English, Spanish] Med Clin (Engl Ed) 2022;158:301–307. doi: 10.1016/j.medcle.2021.03.036. - DOI - PMC - PubMed
    1. The RECOVERY Collaborative Group Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomized, controlled, open-label, platform trial. Lancet. 2021;397:1637–1645. doi: 10.1056/S0140-6736(21)00676-0. - DOI - PMC - PubMed
    1. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. JAMA. 2021;326:499–518. doi: 10.1001/jama.2021.11330. - DOI - PMC - PubMed
    1. The RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693–704. doi: 10.1056/NEJMoa2021436. - DOI - PMC - PubMed
    1. Aomar-Millán I.F., Salvatierra J., Torres-Parejo Ú, Nuñez-Nuñez M., Hernández-Quero J., Anguita-Santos F. Glucocorticoids alone versus tocilizumab alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation [Article in English, Spanish] Med Clin (Barc) 2021;156:602–605. doi: 10.1016/j.medcli.2021.01.006. - DOI - PMC - PubMed

LinkOut - more resources